In a bold move to expand its reach in specialty healthcare, Cardinal Health has announced it will acquire significant assets in gastroenterology and diabetes care through two high-stakes deals worth a combined $3.9 billion. The U.S.-based pharmaceutical and healthcare giant is set to take a controlling interest in GI Alliance, the largest independent gastroenterology care […]
Medical Technology and Devices (MTD) has announced the successful completion of its acquisition of Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses. This strategic move, first revealed in March, represents a significant advancement in MTD’s mission to deliver superior solutions in diabetes and obesity care on a global scale. Strategic Acquisition Bolsters Market […]
Roche has announced a significant advancement in diabetes management with the CE Mark approval of its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. This approval paves the way for the deployment of this cutting-edge technology to adults over the age of 18 who are managing their diabetes with flexible insulin therapy. The Accu-Chek SmartGuide CGM […]
In a strategic move that reshapes the landscape of India’s injectables market, Eris Lifesciences Ltd., a leading player in the branded formulations sector, has announced the acquisition of Biocon Biologics’ India branded formulation business for a hefty sum of INR 1,242 crore. This acquisition not only signifies Eris Lifesciences’ aggressive entry into the burgeoning INR […]